We are live on ! Find out more
RNVA

Rennova Health, Inc.
RNVA

Delisted

RNVA was delisted on the 24th of October, 2017.

2 hedge funds and large institutions have $106K invested in Rennova Health, Inc. in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 42 (-2)

54% less capital invested

Capital invested by funds: $229K → $106K (-$123K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$37K
2
U
UBS
Switzerland
-$12K

RNVA Hedge Fund Activity: Q2 2014 in Review

2 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q2 2014, worth a combined $106K — down 54% from $229K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of RNVA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, exiting entirely with an estimated $37K sold.

  • 2 institutional investors held Rennova Health, Inc. (RNVA) as of Q2 2014, down from 4 in Q1 2014.
  • Funds reported $106K of Rennova Health, Inc. stock for Q2 2014, down 54% quarter-over-quarter.
  • 0 funds opened new Rennova Health, Inc. positions in Q2 2014 and 2 closed out, a net change of -2 holders.
  • The largest Rennova Health, Inc. seller in Q2 2014 was Citadel Advisors, an estimated $37K sold.

Based on aggregated 13F filings for Q2 2014.